Bharat Narahari
About Bharat Narahari
Data last updated:
Bharat Narahari has 13 years in corporate governance. Holds Director role. Currently with 3 companies, including Oncopath Ai Deeptech Private Limited and Neuralbits Technologies Private Limited. Formerly with 1 company, such as Inbotics Technologies Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Current companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
 Oncopath Ai Deeptech Private Limited U72900MH2020PTC348742 | Director | 26 Oct 2020 | 2020 | Active |
 Neuralbits Technologies Private Limited U74120MH2013PTC247088 | Director | 16 Aug 2013 | 2013 | Active |
| Neuralbits Paperless Solutions Private Limited U74999MH2019PTC327845 | Director | 10 Jul 2019 | 2019 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Status |
|---|---|---|---|---|
| Inbotics Technologies Private Limited U72300MH2012PTC238044 | Director | 19 Nov 2012 | 2012 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bharat Narahari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bharat Narahari
Bharat Narahari has 13 years in corporate governance. Holds Director role. Currently with 3 companies, including Oncopath Ai Deeptech Private Limited and Neuralbits Technologies Private Limited. Formerly with 1 company, such as Inbotics Technologies Private Limited. Engaged in Technology, General Business. Contributes to corporate operations.
Bharat Narahari is associated with 3 companies as Director.
Bharat Narahari has expertise in Technology, General Business.
Bharat Narahari has 13 years in corporate governance.